NetworkNewsBreaks – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) CEO Discusses Personalized Immunotherapies in Interview on Uptick Newswire’s Stock Day Podcast

Nov 6, 2018

BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT) an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, was recently featured on Uptick Newswire’s Stock Day Podcast. Dr. Bill Williams, BriaCell’s president and CEO, was interviewed for the podcast by Everett Jolly of Stock Day. Per the interview, Dr. Williams expressed his enthusiasm regarding the company’s future, as he believes BriaCell is on the cutting edge of cancer treatment with its effective and safe immunotherapy applications. Williams also detailed BriaCell’s current major programs: Bria-IMT, which is in the clinic right now, and Bria-OTS, which is in development. “BriaCell is developing the first off-the-shelf, personalized immunotherapy targeting advanced breast cancer,” Dr. Bill Williams, BriaCell’s president and CEO, stated during the interview. “We have a proprietary technology that allows us to target immune responses in breast cancer in a personalized fashion. (The solution) we are working towards is an off-the-shelf immunotherapy which is very similar in some ways to other successful targeted personalized immunotherapies that are not off-the-shelf, are costly, and have been associated with complex manufacturing.”

To listen to the full interview, visit http://nnw.fm/PoA5U

To view the full press release, visit http://nnw.fm/bEBm3

About BriaCell

BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell is currently conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a combination study with pembrolizumab [Keytruda; manufactured by Merck & Co., Inc.] or ipilimumab [Yervoy; manufactured by Bristol-Myers Squibb Company]. The combination study is listed in ClinicalTrials.gov as NCT03328026. BriaCell is developing Bria-OTS, an off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS, which is expected to cover over 90 percent of the patient population, is designed to produce a potent and selective immune response against the cancer of each patient while eliminating the time, expense, and complex manufacturing logistics associated with other personalized immunotherapies. For more information, visit the company’s website at www.BriaCell.com.

More from NetworkNewsBreaks

NetworkNewsBreaks – World Crypto Con Panelists Put Money on the Line to Predict Future of Bitcoin NetworkNewsBreaks – Global Payout, Inc.’s (GOHE) MTrac Team to Host Exhibit at Las Vegas MJBizCon NetworkNewsBreaks – Marijuana Company of America Inc.’s (MCOA) hempSMART Teams with ‘As Seen on TV’ to Launch Pet Product Ad Campaign

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

More News

G7 to release millions of barrels of oil and diesel after Trump threat
Oct 3, 2026
G7 to release millions of barrels of oil and diesel after Trump threat

The co-ordinated release is aimed at heading off further price spikes and avoiding a ban on US diesel exports.

White House Filing Claims President Has Authority to Bar News Outlets
Oct 3, 2026
White House Filing Claims President Has Authority to Bar News Outlets

The Trump administration again defended the decision to bar CNN, MS NOW and Politico from the White House and to exclude journalists from the pool that covers the president in small spaces.

Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon
Oct 3, 2026
Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon

The inquiry by the Commodity Futures Trading Commission centers on bets the former congressman made on Kalshi in the weeks before he was pardoned in January 2025.

US Sanctions A7, a Russia Firm That Helps Sidestep Economic Restrictions
Oct 3, 2026
US Sanctions A7, a Russia Firm That Helps Sidestep Economic Restrictions

The move followed reports detailing how A7, a Moscow firm, uses shell companies around the world to move funds for clients who are themselves subject to sanctions.

G20 trade ministers meet in Wisconsin amid trade tensions
Oct 2, 2026
G20 trade ministers meet in Wisconsin amid trade tensions

G20 trade ministers meet in Wisconsin amid trade tensions

Chinese manufacturers dominate Latin America's bus fleet
Oct 2, 2026
Chinese manufacturers dominate Latin America's bus fleet

Chinese manufacturers dominate Latin America's bus fleet

F.D.A. Found Cyclospora During Taylor Farms Inspection in Mexico
Oct 2, 2026
F.D.A. Found Cyclospora During Taylor Farms Inspection in Mexico

The discovery adds strong evidence that the outbreak that sickened thousands over the summer originated in a grower’s field or processing facility.

The Powerful Yet Fragile Force Propping Up Stocks and the Economy
Oct 2, 2026
The Powerful Yet Fragile Force Propping Up Stocks and the Economy

The artificial intelligence boom has pushed up the stock market, even as interest rates have pulled it down, our columnist says.

Mash-Up of Paramount and Warner Bros. Will Be Called Skydance
Oct 2, 2026
Mash-Up of Paramount and Warner Bros. Will Be Called Skydance

David Ellison, the tech scion who will run the combined company, borrowed the name of his original entertainment company that reflects his love of aviation. On Friday, the C.E.O.s of Warner Bros. were told they would not stay on once the companies merged.

U.S. and Allies Agree to Release Diesel Reserves as Prices Soar
Oct 2, 2026
U.S. and Allies Agree to Release Diesel Reserves as Prices Soar

The Group of 7, which includes Britain, France and Japan, announced the release of 100 million barrels over four months, effective immediately.

Sales of Hulking Pickups and S.U.V.s Sag as Fuel Prices Soar
Oct 2, 2026
Sales of Hulking Pickups and S.U.V.s Sag as Fuel Prices Soar

Sales of big pickup trucks and sport utility vehicles have dipped as more Americans buy hybrids and smaller cars.

Hiring Slows as U.S. Jobs Report Shows Labor Market Shifting Into Lower Gear
Oct 2, 2026
Hiring Slows as U.S. Jobs Report Shows Labor Market Shifting Into Lower Gear

The economy added fewer jobs in September and unemployment ticked up, while inflation has maintained pressure on markets and raised costs.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Marketers Log

Marketers Log is your personal Business & Finance news site to provide marketing or market-related news.

Newsletter